A Phase 1 Pharmacokinetic and Safety Study of Extended Duration, High-Dose Cefixime for Cephalosporin-Resistant Neisseria Gonorrhoeae in the Pharynx

Sexually Transmitted Diseases - United States
doi 10.1097/olq.0000000000000844
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Single-Dose Cefixime Versus Single-Dose Ceftriaxone in the Treatment of Antimicrobial-Resistant Neisseria Gonorrhoeae Infection

Journal of Infectious Diseases
Infectious DiseasesAllergyImmunology
1992English

Comparative Proteomics of Extended-Spectrum Cephalosporin-Resistant Neisseria Gonorrhoeae Isolates Demonstrates Altered Protein Synthesis, Metabolism, Substance Transport, and Membrane Permeability

Frontiers in Microbiology
Microbiology
2020English

Neisseria Gonorrhoeae Treatment Failure and Susceptibility to Cefixime in Toronto, Canada

JAMA - Journal of the American Medical Association
Medicine
2013English

Multidrug-Resistant Neisseria Gonorrhoeae

CMAJ
Medicine
2009English

Ciprofloxacin Resistant Neisseria Gonorrhoeae in the UK.

Sexually Transmitted Infections
DermatologyInfectious Diseases
1990English

Detection of Quinolone-Resistant Neisseria Gonorrhoeae.

Journal of Clinical Microbiology
Microbiology
1996English

Neisseria Gonorrhoeae Resistant to Tetracycline

BMJ
1988English

World-Wide Distribution of High Level Tetracycline-Resistant Neisseria Gonorrhoeae.

Sexually Transmitted Infections
DermatologyInfectious Diseases
1992English

O03.4 Genomic Epidemiology of Neisseria Gonorrhoeae With Reduced Susceptibility to Cefixime in the United States

Sexually Transmitted Infections
DermatologyInfectious Diseases
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy